Meanwhile, our research indicated that regardless of the types of cardiovascular diseases (including valvular heart diseases, cardiomyopathy, etc.), aggressively to reduce Lp(a) concentration may contribute to reduce the incidence of MACEs. This evidence concerns the gene LPA and cardiovascular disorder.